Topics

Companies Related to "A Pilot Study to Explore the Role of Gut Flora in Psoriasis" [Most Relevant Company Matches] RSS

00:25 EST 27th January 2020 | BioPortfolio

Here are the most relevant search results for "A Pilot Study to Explore the Role of Gut Flora in Psoriasis" found in our extensive corporate database of over 50,000 company records.

Showing "Pilot Study Explore Role Flora Psoriasis" Companies 1–25 of 1,400+

Extremely Relevant

International Federation of Psoriasis Associations

The International Federation of Psoriasis Associations (IFPA) is a non profit umbrella organization made up of psoriasis associations from around the world. Today IFPA has 40 member associations. IFPA unites psoriasis associations so that their global campaign for improved medical care, greater public understanding and increased research will improve the l...


Relevant

National Psoriasis Foundation

The National Psoriasis Foundation is the world's largest nonprofit organization serving people with psoriasis and psoriatic arthritis. Our mission is to find a cure for psoriasis and psoriatic arthritis and to eliminate their devastating effects through research, advocacy and education. For more information, call the Psoriasis Foundation, headquartered in Portland, Ore., at 800.723.9166, or visit ...

International Psoriasis Council

The International Psoriasis Council (IPC) is a global non-profit organization dedicated to advancing psoriasis research and treatment by providing a forum for education, collaboration, and innovation among physicians, researchers and other professionals interested in psoriasis.


Psoriasis - Matters

www.psoriasis-matters.co.uk is a specialist psoriasis site brought to you by the same team that developed allergymatters.com . www.psoriasis-matters.co.uk will carry the best range of psoriasis UV UVB Light Therapy units and the most suitable creams, ointments and shampoos available in the market. www.psoriasis-matters.co.uk will provide expert reviews and unbiased psoriasis product ratings to un...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...

Santalis Pharmaceuticals, Inc.

Santalis Pharmaceuticals, Inc. is a wholly-owned subsidiary of TFS Corporation, Ltd. (ASX: TFC). Santalis, and its sister company, ViroXis, were acquired by TFS in July 2015 and are developing scientifically and clinically validated over the counter and prescription products that utilize TFS’ cultivated, sustainable, pharmaceutical-grade East Indian S...

Pilot Pharmaceuticals

Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...

Bio2000

Bio2000 is an organisation whose aim is to encourage research and development of the therapeutic potential of medicinal plants from Peru. For this, Bio2000 designs strategies for the implementation of national collaborative research projects, and evaluates potential international partnerships in order to link the supply of genetic resources to the access of those technologies which make use of the...

Bone Care International Incorporated

Bone Care is a leader in the discovery and development of improved vitamin D-hormone therapies for the treatment of secondary hyperparathyroidism and certain hyperproliferative diseases. D-hormones have a key role in the progression and management of secondary hyperparathyroidism in patient populations with kidney dysfunction, including kidney Dialysis, pre-dialysis, and certain osteoporosis pati...

RESprotect GmbH

RESprotect GmbH from Dresden develops drugs that prevent induction of chemoresistance of tumor cells and enhance their chemosensitivity. This concept is worldwide without concurrence. The first drug RP101 significantly extended survival time of pancreas cancer patients in a clinical pilot study.

The National Stroke Research Institute

The National Stroke Research Institute is directed by Professor Geoffrey Donnan. The NSRI has played a key role in national and international trials of treatment for stroke which have greatly improved services. In addition, the Institute has completed the initial phase of the North East Melbourne Stroke Incidence Study (NEMESIS) in Melbourne. The results from the study will teach us a lot about th...

Alaska Fisheries Development Foundation

Alaska Fisheries Development Foundation is a private non-profit corporation dedicated to creating opportunities out of challenges in Alaska's commercial fishing industry. We help groups join forces to make things happen that otherwise might not.AFDF has been in existence for over 27 years and has a long track record of working with Federal and state fisheries management agencies, the fishing indus...

GALDERMA LABORATORIES L.P.

Since the creation of Galderma in 1981 as a joint venture between Nestlé and L'Oréal, all of our resources have been channelled in one direction: to provide innovative therapeutic solutions that meet the needs of dermatology patients and physicians.Our experience has taught us that the effects of skin conditions reach much deeper than the skin itself. By treating and caring for skin, we help peo...

Data Sciences International (DS)

Founded in 1984, Data Sciences International (DSI) has pioneered the use of wireless implantable devices for monitoring and collecting physiological data to become the global leader in implantable telemetric physiologic monitors. Our technology is the gold standard for monitoring vital signs in animals, which plays an important role in delivering health care to people. In fact, DSI plays an import...

4SC AG

4SC AG (ISIN DE0005753818) is a drug discovery and development company focused on autoimmune and cancer indications. Vidofludimus (4SC-101), a small molecule, is currently in a Phase IIb study in rheumatoid arthritis and a Phase IIa exploratory study in inflammatory bowel disease. The company's lead oncology compound, resminostat (4SC-201), a pan histone d...

Immunomic Therapeutics, Inc. and ZENOAQ

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. ITI has entered into a significant licensing agreement with ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Psoriasis Cure Now

Bioscience Association Manitoba

Read the study here: https://www.biomb.ca/news/reports/561/2019-bam-industry-profile-study

Vascular Dynamics, Inc.

Vascular Dynamics develops catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. Vascular Dynamics was one of nine companies chosen in 2012 by the FDA to participate in the Early Feasibility Study IDE Pilot Program. The company is conducting open-label, controlled, multi...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Zoltan Takacs

Dr. Zoltan Takacs has been researching, publishing, and lecturing about the world of venomous snakes for most of his life. After studying at the Albert Szent-Gyorgyi School of Medicine, Semmelweis Medical School and University of California (UCLA), he obtained his Ph.D. on evolutionary studies on cobra venom from Columbia University. Later he carried out various research projects on snake venom ph...

Immunomic Therapeutics, Inc.(ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. On the heels of two landmark deals in 2015, including an exc...

Immunomic Therapeutics (ITI)

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the LAMP-based nucleic acid immunotherapy platforms. These investigational technologies have the potential to alter how we use immunotherapy for cancer, allergies and animal health. On the heels of two landmark deals in 2015, including an ...


More From BioPortfolio on "A Pilot Study to Explore the Role of Gut Flora in Psoriasis"

Quick Search

Corporate Database Quicklinks